Leidos (LDOS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Leidos (LDOS) reported $4.21 billion in revenue for the quarter ended December 2025, representing a year-over-year decline of 3.6%. EPS of $2.76 for the same period compares to $2.37 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $4.25 billion, representing a surprise of -1.07%. The company delivered an EPS surprise of +7.6%, with the consensus EPS estimate being $2.57.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Leidos performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Health & Civil: $1.21 billion versus the three-analyst average estimate of $1.26 billion. The reported number represents a year-over-year change of -9.3%.
• Revenues- National Security and Digital: $1.85 billion versus the three-analyst average estimate of $1.9 billion. The reported number represents a year-over-year change of -2.5%.
• Revenues- Commercial & International: $610 million versus $568.93 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +1% change.
• Revenues- Defense Systems: $546 million versus $527.48 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +1.3% change.
• Non-GAAP operating income (loss)- National Security and Digital: $208 million compared to the $180.52 million average estimate based on two analysts.
• Non-GAAP operating income (loss)- Health & Civil: $270 million compared to the $273.68 million average estimate based on two analysts.
• Non-GAAP operating income (loss)- Commercial & International: $59 million versus the two-analyst average estimate of $44.62 million.
• Non-GAAP operating income (loss)- Defense Systems: $56 million versus the two-analyst average estimate of $47.23 million.
• Operating income (loss)- Corporate: $-82 million compared to the $-96.01 million average estimate based on two analysts.
• Operating income (loss)- Health & Civil: $264 million compared to the $270.49 million average estimate based on two analysts.
• Operating income (loss)- Commercial & International: $51 million versus $40.48 million estimated by two analysts on average.
• Operating income (loss)- Defense Systems: $44 million versus $32.01 million estimated by two analysts on average.

View all Key Company Metrics for Leidos here>>>

Shares of Leidos have returned -9.5% over the past month versus the Zacks S&P 500 composite's -1.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 
Leidos Holdings, Inc. (LDOS): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research